Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
44.79
-1.18 (-2.57%)
May 9, 2025, 3:04 PM CST
SHE:300347 Revenue
Hangzhou Tigermed Consulting had revenue of 1.56B CNY in the quarter ending March 31, 2025, a decrease of -5.79%. This brings the company's revenue in the last twelve months to 6.51B, down -10.12% year-over-year. In the year 2024, Hangzhou Tigermed Consulting had annual revenue of 6.60B, down -10.58%.
Revenue (ttm)
6.51B
Revenue Growth
-10.12%
P/S Ratio
5.51
Revenue / Employee
638.89K
Employees
10,185
Market Cap
35.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.60B | -780.92M | -10.58% |
Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
Dec 31, 2020 | 3.19B | 388.97M | 13.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |
Hangzhou Tigermed Consulting News
- 9 months ago - Hangzhou Tigermed Consulting reports Q2 results - Seeking Alpha